Skip to main navigation Skip to search Skip to main content

Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science